ArticleOncotarget2026

Retraction: Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells.

Jong-Ok Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.